Akers Biosciences, Inc. (AKR)

Sector:

Health Care

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 19.50p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 102.50
  • 52 Week Low: 15.00
  • Currency: UK Pounds
  • Shares Issued: 94.11m
  • Volume: 0
  • Market Cap: 18.35m
  • RiskGrade: 498
2018-07-02 - Suspension of Listing

1 Day Chart (20-07-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -128.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.1 n/a
Pr/Book 2.6  
Latest F'cast
Revenue 32.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AKR Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 3.58 (1.53) (95.62)¢ n/a n/a n/a n/a 0.0%
31-Dec-14 4.43 (3.13) (66.23)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 2.12 (9.58) (181.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 2.96 (3.30) (61.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 3.93 (5.81) (61.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AKR Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

AKR Company Announcements

Issue of Equity 20-Jul-2018 15:05 RNS
Correction: Issue of Equity 20-Jul-2018 15:00 RNS
1st Quarter 2018 Results 16-Jul-2018 07:03 RNS

Latest AKR Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AKR Market Data

Currency UK Pounds
Share Price 19.50p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 102.50
52 Week Low 15.00
Volume 0
Shares Issued 94.11m
Market Cap 18.35m
RiskGrade 498

AKR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.42% below the market average43.42% below the market average43.42% below the market average43.42% below the market average43.42% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Value
43.42% below the market average43.42% below the market average43.42% below the market average43.42% below the market average43.42% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
55.67% above the market average55.67% above the market average55.67% above the market average55.67% above the market average55.67% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

AKR Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

AKR Key Personnel

CEO John J. Gormally

Top of Page